harmonisation
Is the European Harmonisation of HTA Worth Pursuing?
February 23 by Pharmaceuticals & Biotechnology EditorAnsgar Hebborn, Head of the Global Payer & HTA Program Policy at F Hoffmann-La Roche, joins Tim Haïdar from Pharma IQ, to analyse major trends and implications for the research-ba...
Top 3 Best Practices for Complying with the Development Safety Update Report (DSUR)
January 06 by Andrea CharlesPilar Carrero, Director of Safety Medical Writing at Novo Nordisk, joined Pharma IQ to discuss the impact social media has had on drug safety and risk management and the dawn of a new era for p...
A Year in European Variations Regulation
December 20 by Pharma IQVariations, regardless of their simplicity, are still required to pass through a complex regulatory process for the products to remain authorised for sale on the market. The process is essential...
What is the Future for the Clinical Trials Directive?
November 01 by Pharma IQ NewsWhat are the 7 Deadly Sins of Quality Assurance and Quality Control? Download our free QA QC eBook now to find out! Harmonisation, harmonisation, harmonisatio...
Post & Pre Marketing Pharmacovigilance in Asia by 2020: Solvay Pharmaceuticals
April 27 by Rashmi HegdeDr. Rashmi Hegde, Solvay Pharmaceuticals’ Director Pharmacovigilance Asia-Middle East-Australia-Canada expects to see “mature post-marketing regulations and acceptable regulations with r...